F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Lenvatinib

Page 1 of 1 ( 42 items )
<<
1
>>

1	AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma 12/27/2025 2:50:52 AM \| Browse: 79 \| Download: 301
2	Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after lenvatinib therapy 12/19/2025 10:39:42 AM \| Browse: 79 \| Download: 351
3	Molecular biomarkers of sintilimab plus lenvatinib in hepatitis-B-virus-associated hepatocellular carcinoma 11/27/2025 7:53:56 AM \| Browse: 76 \| Download: 360
4	Personalized prognosis in unresectable hepatocellular carcinoma: Development and validation of a model for transcatheter arterial chemoembolization plus lenvatinib 11/14/2025 12:56:25 AM \| Browse: 69 \| Download: 343
5	Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy 8/7/2025 6:39:58 AM \| Browse: 151 \| Download: 448
6	Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature 7/14/2025 12:55:54 PM \| Browse: 122 \| Download: 495
7	Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus 6/20/2025 8:05:12 AM \| Browse: 114 \| Download: 996
8	Transarterial chemoembolization combined with lenvatinib vs transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis 6/13/2025 1:39:35 PM \| Browse: 156 \| Download: 682
9	Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy 2/26/2025 4:21:32 AM \| Browse: 174 \| Download: 571
10	Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report 2/24/2025 9:25:50 AM \| Browse: 178 \| Download: 632
11	CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma 1/20/2025 7:38:49 AM \| Browse: 134 \| Download: 657
12	Transarterial chemoembolization combined with lenvatinib and sintilimab vs lenvatinib alone in intermediate-advanced hepatocellular carcinoma 12/12/2024 9:30:58 AM \| Browse: 144 \| Download: 769
13	Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma? 11/12/2024 12:23:36 PM \| Browse: 132 \| Download: 565
14	Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma 10/25/2024 10:27:34 AM \| Browse: 152 \| Download: 648
15	Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy 9/26/2024 10:17:46 AM \| Browse: 137 \| Download: 528
16	Unresectable hepatocellular carcinoma: Transarterial chemoembolization combined with lenvatinib in combination with programmed death-1 inhibition is a possible approach 9/26/2024 10:17:46 AM \| Browse: 163 \| Download: 526
17	Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 9/26/2024 8:22:28 AM \| Browse: 161 \| Download: 747
18	Effectiveness of transarterial chemoembolization in combination with lenvatinib and programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 166 \| Download: 531
19	Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 6/15/2024 2:49:03 AM \| Browse: 219 \| Download: 1119
20	Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature 4/11/2024 2:23:40 AM \| Browse: 158 \| Download: 832
21	Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma 4/11/2024 2:23:39 AM \| Browse: 179 \| Download: 787
22	Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus 2/26/2024 1:28:46 PM \| Browse: 260 \| Download: 933
23	Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma 1/11/2024 5:28:09 AM \| Browse: 360 \| Download: 1271
24	Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature 11/15/2023 1:46:53 PM \| Browse: 412 \| Download: 1286
25	Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma 3/10/2023 7:29:15 AM \| Browse: 402 \| Download: 1409
26	Systemic treatment for unresectable hepatocellular carcinoma 3/10/2023 7:29:15 AM \| Browse: 347 \| Download: 1056
27	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 753 \| Download: 2108
28	Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment 7/13/2022 7:31:00 AM \| Browse: 530 \| Download: 1805
29	Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report 4/8/2022 12:06:55 PM \| Browse: 608 \| Download: 1786
30	Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report 3/25/2022 2:25:11 PM \| Browse: 587 \| Download: 1896
31	Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy 12/14/2021 11:58:13 PM \| Browse: 492 \| Download: 1632
32	Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma 12/14/2021 11:58:13 PM \| Browse: 615 \| Download: 1876
33	Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma 9/18/2021 1:32:04 PM \| Browse: 600 \| Download: 1621
34	Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials 5/13/2021 10:05:39 AM \| Browse: 777 \| Download: 1976
35	Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report 4/20/2021 12:49:51 PM \| Browse: 814 \| Download: 1549
36	Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report 3/20/2021 2:13:53 AM \| Browse: 730 \| Download: 1810
37	Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report 12/18/2020 5:58:43 AM \| Browse: 840 \| Download: 1669
38	Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China 8/14/2020 12:33:31 PM \| Browse: 1188 \| Download: 3211
39	Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports 6/24/2020 7:33:17 AM \| Browse: 881 \| Download: 2009
40	Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma 5/20/2019 9:05:36 AM \| Browse: 948 \| Download: 2321
41	Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond 2/21/2019 9:31:55 AM \| Browse: 1351 \| Download: 1763
42	Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma 5/15/2018 7:28:22 AM \| Browse: 1469 \| Download: 1923

Page 1 of 1 ( 42 items )
<<
1
>>

1	AADN score: Predicting response to transarterial chemoembolization, sintilimab and lenvatinib in patients with hepatocellular carcinoma 12/27/2025 2:50:52 AM \| Browse: 79 \| Download: 301
2	Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after lenvatinib therapy 12/19/2025 10:39:42 AM \| Browse: 79 \| Download: 351
3	Molecular biomarkers of sintilimab plus lenvatinib in hepatitis-B-virus-associated hepatocellular carcinoma 11/27/2025 7:53:56 AM \| Browse: 76 \| Download: 360
4	Personalized prognosis in unresectable hepatocellular carcinoma: Development and validation of a model for transcatheter arterial chemoembolization plus lenvatinib 11/14/2025 12:56:25 AM \| Browse: 69 \| Download: 343
5	Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy 8/7/2025 6:39:58 AM \| Browse: 151 \| Download: 448
6	Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature 7/14/2025 12:55:54 PM \| Browse: 122 \| Download: 495
7	Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus 6/20/2025 8:05:12 AM \| Browse: 114 \| Download: 996
8	Transarterial chemoembolization combined with lenvatinib vs transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis 6/13/2025 1:39:35 PM \| Browse: 156 \| Download: 682
9	Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy 2/26/2025 4:21:32 AM \| Browse: 174 \| Download: 571
10	Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report 2/24/2025 9:25:50 AM \| Browse: 178 \| Download: 632
11	CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma 1/20/2025 7:38:49 AM \| Browse: 134 \| Download: 657
12	Transarterial chemoembolization combined with lenvatinib and sintilimab vs lenvatinib alone in intermediate-advanced hepatocellular carcinoma 12/12/2024 9:30:58 AM \| Browse: 144 \| Download: 769
13	Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma? 11/12/2024 12:23:36 PM \| Browse: 132 \| Download: 565
14	Drug-eluting beads chemoembolization combined with programmed cell death 1 inhibitor and lenvatinib for large hepatocellular carcinoma 10/25/2024 10:27:34 AM \| Browse: 152 \| Download: 648
15	Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy 9/26/2024 10:17:46 AM \| Browse: 137 \| Download: 528
16	Unresectable hepatocellular carcinoma: Transarterial chemoembolization combined with lenvatinib in combination with programmed death-1 inhibition is a possible approach 9/26/2024 10:17:46 AM \| Browse: 163 \| Download: 526
17	Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 9/26/2024 8:22:28 AM \| Browse: 161 \| Download: 747
18	Effectiveness of transarterial chemoembolization in combination with lenvatinib and programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma 7/12/2024 3:55:58 PM \| Browse: 166 \| Download: 531
19	Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy 6/15/2024 2:49:03 AM \| Browse: 219 \| Download: 1119
20	Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature 4/11/2024 2:23:40 AM \| Browse: 158 \| Download: 832
21	Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma 4/11/2024 2:23:39 AM \| Browse: 179 \| Download: 787
22	Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus 2/26/2024 1:28:46 PM \| Browse: 260 \| Download: 933
23	Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma 1/11/2024 5:28:09 AM \| Browse: 360 \| Download: 1271
24	Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature 11/15/2023 1:46:53 PM \| Browse: 412 \| Download: 1286
25	Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma 3/10/2023 7:29:15 AM \| Browse: 402 \| Download: 1409
26	Systemic treatment for unresectable hepatocellular carcinoma 3/10/2023 7:29:15 AM \| Browse: 347 \| Download: 1056
27	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 753 \| Download: 2108
28	Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment 7/13/2022 7:31:00 AM \| Browse: 530 \| Download: 1805
29	Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report 4/8/2022 12:06:55 PM \| Browse: 608 \| Download: 1786
30	Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report 3/25/2022 2:25:11 PM \| Browse: 587 \| Download: 1896
31	Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy 12/14/2021 11:58:13 PM \| Browse: 492 \| Download: 1632
32	Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma 12/14/2021 11:58:13 PM \| Browse: 615 \| Download: 1876
33	Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma 9/18/2021 1:32:04 PM \| Browse: 600 \| Download: 1621
34	Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials 5/13/2021 10:05:39 AM \| Browse: 777 \| Download: 1976
35	Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report 4/20/2021 12:49:51 PM \| Browse: 814 \| Download: 1549
36	Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report 3/20/2021 2:13:53 AM \| Browse: 730 \| Download: 1810
37	Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report 12/18/2020 5:58:43 AM \| Browse: 840 \| Download: 1669
38	Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China 8/14/2020 12:33:31 PM \| Browse: 1188 \| Download: 3211
39	Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports 6/24/2020 7:33:17 AM \| Browse: 881 \| Download: 2009
40	Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma 5/20/2019 9:05:36 AM \| Browse: 948 \| Download: 2321
41	Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond 2/21/2019 9:31:55 AM \| Browse: 1351 \| Download: 1763
42	Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma 5/15/2018 7:28:22 AM \| Browse: 1469 \| Download: 1923